Titlebook: Regression of Atherosclerotic Lesions; Experimental Studies M. Rene Malinow,Victor H. Blaton Book 1984 Springer Science+Business Media New

冷峻

Book 1984, September 11-13, 1983. The institute was designed to foster discussion of experimental data on the regression of atherosclerosis in animals and evidence of a similar phenomenon in humans. The participating scientists showed with anatomical and biochemical data, that atherosclerosis regresses in ch

Infelicity

Plant Glycosides: Effects on Atherosclerosis Regression in ,duced by a high-cholesterol diet there is a remarkable decrease in lumen stenosis when the animals are shifted to a low-cholesterol diet. Their observations have been confirmed in the same species by Clarkson et al.,. Stary,. Eggen et al.,. and Wissler,. and have been extended to cynomolgus macaques (.) by others..

promote

Musket

Evolution of Human Atherosclerotic Lesionsanced Study Institute is all about), then it is necessary first to try to understand how those risk factors accessible to therapeutic intervention might operate in the arterial wall to cause . of the disease.

暫時(shí)過(guò)來(lái)

Possible Recognition of Atherosclerosis Regression in Humans Where the incidence of diseases associated with atherosclerosis is decreasing, it is not clear whether the phenomenon is due to prevention of the occurrence of arterial disease, to slowing of its rate of progress, to an actual regression of established disease, or even to all three of these events.

不能和解

exhilaration

The Pathobiology of the Atherosclerotic Plaque in the Mid-1980s symptoms and most of the life-threatening effects of atherosclerosis which result in its being the leading cause of death and morbidity in the urban-industrial countries of the world, especially in Europe and North America.

說(shuō)不出

High-Density Lipoproteins and Their Role in Preventing or Retarding Atherosclerosiswhom CHD does not develop).. With these results as a basis, it is not possible, in an individual case involving a total cholesterol level between 150 and 300 mg/dl, to make a statement regarding coronary risk.

投票

隨意

Giorgio Weber,Piera Fabbrini,Loretta Resi,Piero Tanganelli